NasdaqCM - Nasdaq Real Time Price USD
BioCardia, Inc. (BCDA)
2.3200
-0.4700
(-16.85%)
At close: May 15 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 349,862 | 20 |
| Sales | 3,257 | 1 |
| Net Shares Purchased (Sold) | 346,605 | 21 |
| Total Insider Shares Held | 1.12M | -- |
| % Net Shares Purchased (Sold) | 44.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ALTMAN PETER Chief Executive Officer | Purchase at price 1.90 per share. | Direct | 49,999 | Apr 23, 2025 |
| STERTZER SIMON H Director | Purchase at price 1.90 per share. | Indirect | 199,998 | Apr 23, 2025 |
| BLANK ANDREW SCOTT Director | Purchase at price 1.90 per share. | Indirect | 249,999 | Apr 23, 2025 |
| FACTEAU BILL Director | Purchase at price 1.90 per share. | Direct | 24,999 | Apr 23, 2025 |
| KRASNO RICHARD M Director | Purchase at price 1.90 per share. | Direct | 24,999 | Apr 23, 2025 |
| MCCLUNG DAVID Chief Financial Officer | Purchase at price 1.90 per share. | Direct | 24,999 | Apr 23, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.14 per share. | Direct | 214 | Apr 15, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 1.99 - 2.03 per share. | Direct | 1,206 | Apr 11, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 1.96 per share. | Direct | 980 | Apr 7, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.04 per share. | Direct | 1,632 | Apr 4, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.24 per share. | Direct | 2,688 | Apr 3, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.20 - 2.23 per share. | Direct | 2,435 | Apr 3, 2025 |
| STERTZER SIMON H Director | Purchase at price 2.45 per share. | Direct | 2,450 | Mar 5, 2025 |
| STERTZER SIMON H Director | Purchase at price 2.30 per share. | Direct | 88,065 | Mar 4, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.11 per share. | Direct | 1,055 | Mar 3, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.48 per share. | Direct | 1,488 | Feb 7, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.38 - 2.40 per share. | Direct | 1,769 | Jan 30, 2025 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.06 per share. | Direct | 2,060 | Dec 23, 2024 |
| GILLIS EDWARD M Officer | Sale at price 2.00 per share. | Direct | 6,514 | Dec 20, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.22 per share. | Direct | 555 | Dec 5, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 1.87 per share. | Direct | 2,524 | Nov 15, 2024 |
| MCCLUNG DAVID Chief Financial Officer | Stock Award(Grant) at price 2.65 per share. | Direct | 64,111 | Oct 11, 2024 |
| ALTMAN PETER Chief Executive Officer | Stock Award(Grant) at price 2.65 per share. | Direct | 117,262 | Oct 11, 2024 |
| MCCLUNG DAVID Chief Financial Officer | Stock Award(Grant) at price 3.00 per share. | Direct | 24,999 | Sep 3, 2024 |
| ALTMAN PETER Chief Executive Officer | Stock Award(Grant) at price 3.00 per share. | Direct | 124,998 | Sep 3, 2024 |
| BLANK ANDREW SCOTT Director | Stock Award(Grant) at price 3.00 per share. | Indirect | 333,000 | Sep 3, 2024 |
| ALLEN JIM L Director | Stock Award(Grant) at price 3.00 per share. | Direct | 150,000 | Sep 3, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 2.99 - 3.05 per share. | Direct | 1,513 | Jul 1, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 3.29 per share. | Direct | 1,645 | Jun 21, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 3.52 per share. | Direct | 1,760 | Jun 14, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 3.36 per share. | Direct | 3,360 | Jun 10, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 0.37 per share. | Direct | 1,013 | Apr 19, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 0.39 per share. | Direct | 195 | Mar 28, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 0.46 per share. | Direct | 50,000 | Feb 13, 2024 |
| FROST PHILLIP MD ET AL Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.43 per share. | Indirect | 55,815 | Jan 19, 2024 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 0.87 per share. | Direct | 3,484 | Aug 17, 2023 |
| ALTMAN PETER Chief Executive Officer | Stock Award(Grant) at price 0.87 per share. | Direct | 3,484 | Aug 17, 2023 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 0.88 per share. | Direct | 3,978 | Aug 14, 2023 |
| ALTMAN PETER Chief Executive Officer | Stock Award(Grant) at price 0.88 per share. | Direct | 3,978 | Aug 14, 2023 |
| MCCLUNG DAVID Chief Financial Officer | Stock Award(Grant) at price 2.34 per share. | Direct | 9,998 | Jun 23, 2023 |
| ALTMAN PETER Chief Executive Officer | Stock Award(Grant) at price 2.34 per share. | Direct | 14,999 | Jun 23, 2023 |
| STERTZER SIMON H Director | Stock Award(Grant) at price 2.34 per share. | Direct | 149,999 | Jun 23, 2023 |
| BLANK ANDREW SCOTT Director | Stock Award(Grant) at price 2.34 per share. | Direct | 149,999 | Jun 23, 2023 |
| ALLEN JIM L Director | Stock Award(Grant) at price 2.34 per share. | Direct | 149,999 | Jun 23, 2023 |
| ALTMAN PETER Chief Executive Officer | Purchase at price 1.60 per share. | Direct | 9,920 | May 26, 2023 |
| GILLIS EDWARD M Officer | Stock Award(Grant) at price 1.70 per share. | Direct | 68,833 | May 18, 2023 |
| MCCLUNG DAVID Chief Financial Officer | Stock Award(Grant) at price 1.70 per share. | Direct | 104,361 | May 18, 2023 |
| ALTMAN PETER Chief Executive Officer | Stock Award(Grant) at price 1.70 per share. | Direct | 185,851 | May 18, 2023 |
Related Tickers
SLXN Silexion Therapeutics Corp
0.9647
+2.20%
ADIL Adial Pharmaceuticals, Inc.
0.6600
+1.54%
QLGN Qualigen Therapeutics, Inc.
3.9400
+2.60%
ICU SeaStar Medical Holding Corporation
1.2400
+0.81%
BRTX BioRestorative Therapies, Inc.
1.6700
-2.34%
TCBPY TC Biopharm (Holdings) Plc
0.3100
-4.23%
UNCY Unicycive Therapeutics, Inc.
0.5506
-1.38%
QNRX Quoin Pharmaceuticals, Ltd.
7.70
+0.65%
BDRX Biodexa Pharmaceuticals Plc
1.3000
-0.76%
OABI OmniAb, Inc.
1.5500
+1.97%